Atlanta Cancer Care-Roswell

Roswell, Georgia 30076

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Multiple Myeloma and Plasma Cell Neoplasm, Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Studies at this site

• Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma — Completed
• Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma — Withdrawn before enrolling